Proteomics International Laboratories Ltd.ASX: PIQ

PromarkerD US reimbursement price & Aus regulatory decision

· Issued by Proteomics International Laboratories Ltd.

Filed with ASX · · 3 pages · English

 Centers for Medicare & Medicaid Services (CMS) list PromarkerD predictive test for diabetic kidney disease and assign payment rate of US$390.75 in the United States  CMS is the single largest payer for health care in the United States, with Medicare and Medicaid collectively responsible for 42 per cent of healthcare spending and providing health coverage to more than 100 million Americans  The

Proteomics International Laboratories Ltd. on 6ix

Earlier from Proteomics International Laboratories

Later from Proteomics International Laboratories

All Proteomics International Laboratories news releases